Cardiol Therapeutics (CRDL) Change in Account Payables (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Change in Account Payables came in at $1.2 million in Q1 2026, up 138.73% YoY from $515505.6 in Q1 2025, and up 149.06% on a QoQ basis from -$2.5 million in Q4 2025.
Cardiol Therapeutics (CRDL) Change in Account Payables (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Change in Account Payables data on file, last reported at $1.2 million in Q1 2026.
- Quarterly Change in Account Payables rose 138.73% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $916876.1 (up 205.04% YoY) and the FY2025 annual result came in at $189087.8, up 124.81% from the prior year.
- Change in Account Payables rose to $1.2 million in Q1 2026, from -$2.5 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.0 million in Q3 2025 to a low of -$2.5 million in Q4 2025.
- A 5-year average of $183612.9 and a median of $488094.6 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables surged 1125.24% — and 2024, when it slumped 13493.07%.
- Tracing CRDL's Change in Account Payables over 5 years: stood at $1.2 million in 2022, then tumbled by 49.56% to $624557.2 in 2023, then dropped by 21.85% to $488094.6 in 2024, then slumped by 613.9% to -$2.5 million in 2025, then jumped by 149.06% to $1.2 million in 2026.
- The last three Change in Account Payables figures came in at $1.2 million (Q1 2026), -$2.5 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Cardiol Therapeutics | 213.21 Mn | 194.35 Mn | - | 194,815.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.23 Mn |
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | -2.51 Mn |
| Dec 31, 2025 | -2.51 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 195,467.89 |
| Jun 30, 2025 | 195,467.89 |
| Mar 31, 2025 | 515,505.63 |
| Mar 31, 2025 | 515,505.63 |
| Dec 31, 2024 | 488,094.58 |
| Dec 31, 2024 | 488,094.58 |
| Sep 30, 2024 | -2.30 Mn |
| Sep 30, 2024 | -2.30 Mn |
| Jun 30, 2024 | 422,792.26 |
| Jun 30, 2024 | 422,792.26 |
| Mar 31, 2024 | 602,379.23 |
| Mar 31, 2024 | 602,379.23 |
| Dec 31, 2023 | 624,557.20 |
| Dec 31, 2023 | 624,557.20 |